NOTICE OF THE ANNUAL GENERAL MEETING IN PROLIGHT DIAGNOSTICS AB (PUBL)
The shareholders in Prolight Diagnostics AB (publ), corp. reg. no. 556570-9499, (the ”Company”) are hereby notified of the annual general meeting to be held on Tuesday 14 May 2024 at 1 p.m. at the Company’s office, Gasverksgatan 3 A, 222 29 Lund, Sweden. Notification of attendanceShareholders who wish to participate in the annual general meeting […]
BioStock publishes article about Prolight Diagnostics’ collaboration with G&H | ITL
Prolight Diagnostics have appointed G&H | ITL for the development of its innovative point-of-care system, Psyros. The development project started in early 2023 and is steadily progressing. BioStock reached out to G&H’s CEO Charlie Peppiatt and Prolight Diagnostics’ Head of Engineering, Paul Monaghan, to gain further insight into the current status of development. Read the […]
BioStock publishes article about Prolight Diagnostics’ partnership with FlexMedical Solutions
Prolight Diagnostics has appointed FlexMedical Solutions as contract manufacturing partner for the disposable cartridge in the Psyros point-of-care system. Prolight’s COO, Karl Bullen, has highlighted the simplicity and cost-effectiveness of the cartridge as a key competitive advantage. BioStock reached out to Karl to learn more. Read the full article at: https://www.biostock.se/en/2024/04/prolights-coo-comments-on-partnership-with-flexmedical-solutions/ For further information, please […]
TTP will present the POC system MicroFlex at the ECCMID in Barcelona April 27-30
TTP (The Technology Partnership ltd) will present the POC-system MicroFlex at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Barcelona, April 27-30. As the world’s premier Clinical Microbiology & Infectious Diseases event, ECCMID brings together experts from many fields to present their latest findings, guidelines, and experiences to an audience of over 14,000 […]
Prolight Diagnostics selects FlexMedical Solutions as CMO partner
Prolight Diagnostics, developer of the digital point-of-care platform Psyros™, has appointed FlexMedical Solutions (FlexMedical) as its chosen Contract Manufacturing partner for the Psyros™ disposable cartridge. “The partnership is a major step in the development of the pilot manufacturing capabilities utilizing FlexMedical’s existing fully validated facilities and extensive IVD experience. One of the unique selling points […]
BioStock publishes interview of Prolight Diagnostics CTO Steve Ross
BioStock talked to Steve Ross, co-founder of Psyros Diagnostics, which was acquired by Prolight Diagnostics in 2022. He and the other co-founders play a crucial role in steering the continued development of the point-of-care system Psyros. Together, as a team, they have previously navigated the full process of developing a POC system, from conceptualization to […]
Biostock publishes article about Prolight Diagnostics Q4 report
Prolight Diagnostics’ year-end report for 2023 shows that the company met all the goals for the year. The company’s point-of-care analysis system has shown proof-of-performance for measurement of troponin in whole blood. In addition, the company has formed a Clinical Advisory Board and established an R&D manufacturing line for the upcoming pilot production. The goal […]
Prolight Diagnostics publishes year-end report 2023
Financial overview Fourth quarter, 1 October – 31 December, Q4 2023 Group(figures in the brackets refer to the corresponding period in previous year) • Net sales amounted to 0 (0).• Other operating income amounted to kSEK 5,941 (2,051).• The profit after tax amounted to kSEK -2,382 (-2,809).• Earnings per share before and after dillution: SEK […]
Emergers initiates equity research coverage of Prolight Diagnostics
Equity research firm Emergers has initiated coverage of Prolight Diagnostics. Excerpt from the equity research report: Having already achieved proof-of-performance for its proprietary digital technique for detection of high-sensitive biomarkers in low concentrations by counting single molecules, Prolight’s first objective is now to pioneer the Point-of-Care (POC) troponin market. Next steps involve prototype development and […]
Biostock publishes article about the high interest of POC systems and the latest acquisitions on the market
Biostock published on January 29 an article about the high interest for POC systems and the latest acquisitions. Prolight Diagnostics CEO Ulf Bladin comments on the acquisition and shares the company´s partnership ambitions. Read the full article at https://prolightdx.com/en/mediaeng/articles/. For further information, please contact:Prolight Diagnostics AB (publ)E-mail: info@prolightdx.comTelephone: +46 73 582 39 87Website: www.prolightdx.com/en/ About […]
